Is Anthem Biosciences IPO a risky bet for investors?

July 14, 2025

Anthem Biosciences, a CRDMO, is set to launch an IPO to raise ₹3,395 crore, diluting the promoter group’s stake. While revenue and profit have increased, the company faces geographical and client concentration risks. Despite a high P/E ratio compared to peers, investors with a high-risk tolerance may find the IPO appealing.

More To Explore

Oil disruption fears and war rhetoric keeping markets on edge: Santosh Rao

Global markets are on edge due to ongoing geopolitical tensions. Investors face uncertainty about equities and the global economy. Sharp market swings are occurring as

March 6, 2026

Markets still digesting West Asia shock; domestic sectors offer relative comfort, says Dharmesh Kant

Market experts advise caution despite a brief equity rebound, citing ongoing global uncertainties and geopolitical tensions. Analysts believe the market has not fully absorbed the

March 6, 2026

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003